Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I'm readying to load up more CYDY shares even tho trial completion is eons away.
It doesn't change the fact Leronlimab saved the lives of those people. Positive response leads to approval.
There's another side to your reaction also. They met the endpoints to HIV trial had a couple minor problems with the BLA that have been corrected and approval is coming soon.
It's simple, it's called revenue from HIV. You keep talking about RS for CYDY but the only ones here talking about it are HGEN investors. CYDY doesn't have the problems that caused HGEN to RS. You should be more concerned with your failing investment in HGEN rather than our investment in CYDY.
Nothing positive happening with this company. It's a game for baiters and Longs are on the hook. Clever Mgmt knows how to bilk some Longs.
The majority of small bios that get bought have just the one drug with one indication. After taking 10 or 20 years to develop the drug it makes perfect sense to sell. That's not the case with CytoDyn with their one drug having multiple indications they have the opportunity to become a major pharma company. It would cost a pharma company hundreds of billions of dollars to R&D that many drugs.
For your CYDY $20 PX what is your target date?
NASDAQ news coming tomorrow or Friday
It's a trial, that's how it works. Positive is still positive. So what you're saying is when they up the dose it will be even better? What's wrong with that??
5 patients from the cancer basket trial showing positive results is big news.
You're right CYDY is going higher than 15 billion market cap after first approval. First approval opens the door for other indications and that's what institution/bank buyers are waiting on. Retail Investors alone will push CYDY to $20 easy.
Hey justdafactss is CYDY hitting $20 from NASDAQ uplist, HIV, COVID, Cancer?
WOW! JUSTDAFACTSS CYDY PT $20
Covid cure and other catalyst, there are many. Do some DD on Leronlimab.
I'm readying to read Talk Market to inflae CYDY's story
Looks like someone is desperate to cover their CYDY short position today, starting to panic
Nasdaq uplist PR 4:01?
Over the weekend it was $3-$3.50, yesterday it was $3.50, today it was $3.50-$3.75. sounds like the chase is on.
I sho is disappointed, I was readying to buy CYDY at $3.50 today.
Let's try it in a sentence...hey y'all I be readying to short CYDY
Mystery of the day..what is readying?
CC TOMORROW VERY SUCCESSFUL MEETING WITH FDA
This university is currently working with GNPX on a cure for diabetes. It's possible they would partner with them on this one. Would takes months just for safety alone if approved for a trial.
How is this misleading?! Regardless of how long it's been there, ITS THERE. The only reason a company would hire this position is to prepare for what's to come, and that would be to manage inventory.
CytoDyn hiring an inventory manager
The Company is seeking a Cost & Inventory Accounting Manager who will play a key role in the development, implementation and maintenance of inventory and cost accounting, and cost of goods sold analysis. This position will, while partnering with other key functional areas such as Manufacturing and Supply Chain, implement new processes as the Company prepares for commercialization. Reporting to the Corporate Controller, the candidate will be responsible for the day-to-day inventory and cost accounting operations, the month-end close and related reporting process. The ideal candidate has proven operational experience from companies with commercial product(s) within the life science industries, especially biotech.
Very interesting indeed. A company doesn't hire an inventory manager if there's no inventory to manage. That screams approval. And the SEC position looks NASDAQ related.
Leronlimab saved countless lives during the HIV trial including Charlie Sheen. And now Leronlimab continues to save lives in covid and cancer trials.
I just checked the charts for CYDY they are predicting a major catalyst to launch the SP in the near future. Could be as early as this week.
Yesterday you said $3 now it's $3.50?
Looks like the chart princess was wrong again. CYDY didn't open at $3.50. She really is struggling with this whole T/A thing. Hey chart princess there's a book on Amazon for $12.95 that can teach you a thing or two about reading charts.
Hey hopester, why are you so giddy about a .60 drop in a stock you own? You are one strange lady.
CYDY $100 COVID,HIV,CANCER APPROVAL
CYDY $50 WITH COVID,HIV APPROVAL
Give me a legitimate reason you think Leronlimab will not be approved for covid19. And Nader makes grip sad won't work.
CYDY $30 WITH COVID APPROVAL
HGEN? Didn't their trial get halted? Isn't that why the stock is dumping? Don't forget to tell everyone about the 5 for one reverse split. One week after the split SP will be right back at $2
CYDY is $4.80 on TDA, insiders know something???
That's not an FDA calendar. That's a private website companies pay to advertise on.
DEBUNKED
Nasdaq uplist, PR in the morning after the market opens would be hilarious. The shorts are in a panic right now that would send them into a frenzy.